Enanta Pharmaceuticals reported $-33847000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Acorda Therapeutics ACOR:US $ -13503000 3.34M
Amgen AMGN:US $ 2500M 196M
Anika Therapeutics ANIK:US $ -3554000 5.35M
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN 2.88B 1.57B
Biocryst Pharmaceuticals BCRX:US $ -49957000 2.22M
Biogen BIIB:US $ 531.5M 11.7M
Bristol Myers Squibb BMY:US $ 3188M 399M
Clovis Oncology CLVS:US $ -50359000 2.35M
Enanta Pharmaceuticals ENTA:US $ -33847000 3.44M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62923000 9.39M
Insmed INSM:US $ -101451000 1.41M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Johnson & Johnson JNJ:US $ 7540M 1623M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Ligand Pharmaceuticals LGND:US $ -9306000 22.04M
Marinus Pharmaceuticals MRNS:US -16711000 10.4M
Merk MRK:US $ 5059M 207M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Novavax NVAX:US $ 209.29M 1.03B
Pfizer PFE:US $ 9995M 4136M
Ptc Therapeutics PTCT:US $ -86522000 1.79M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
Vital Therapies VTL:US $ -21435000 286K
YTE INCY:US $ 127.66M 7.71M